BAV Stock Chart & Stats
€0.14
>-€0.01(-2.50%)
At close: 4:00 PM EDT
€0.14
>-€0.01(-2.50%)
Day’s Range― - ―
52-Week Range€0.12 - €0.26
Previous CloseN/A
Volume0.00
Average Volume (3M)11.00
Market Cap
€45.13M
Enterprise Value€59.64M
Total Cash (Recent Filing)€22.50M
Total Debt (Recent Filing)€10.53M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Mar 17, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding436,874,180
10 Day Avg. Volume33
30 Day Avg. Volume11
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.44
Price to Sales (P/S)0.75
P/FCF Ratio-10.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€1.10M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRevenue has returned to growth and accelerated materially in 2025, indicating improving demand for BATM’s offerings. If sustained, stronger top-line momentum can support operating leverage, broaden customer adoption, and provide a foundation for restoring profitability over the next several quarters.
Conservative LeverageLow leverage limits the burden of interest and debt repayment, giving BATM more financial flexibility than a highly indebted technology business. This balance-sheet cushion can help the company fund restructuring, product development, or growth initiatives while reducing refinancing exposure.
Diversified Networking And Cybersecurity PlatformExposure to both carrier-grade networking and cybersecurity gives BATM multiple technology markets and customer groups rather than dependence on one narrow application. Direct sales and channel partners can also extend geographic reach and support recurring software, support, and service revenue.
Bears Say
Persistent Net LossesLarge net losses indicate that revenue growth is not yet translating into dependable earnings. Continued losses can constrain investment capacity, weaken stakeholder confidence, and make future performance highly dependent on a sustained improvement in operating margins and cost discipline.
Negative Operating And Free Cash FlowRecent cash consumption shows that the business is not currently self-funding its operations and investment needs. If negative operating and free cash flow persists, BATM may have less flexibility to develop products, support customers, or absorb execution setbacks without using its balance-sheet resources.
Eroding Equity BaseThe substantial decline in shareholders’ equity reflects the cumulative effect of multi-year losses and reduces the capital buffer supporting the business. Negative returns on equity also show that the remaining capital is currently producing poor results, increasing pressure to restore sustainable profitability.
BATM Advanced Communications News
BAV FAQ
What was BATM Advanced Communications’s price range in the past 12 months?
BATM Advanced Communications lowest stock price was €0.12 and its highest was €0.26 in the past 12 months.
What is BATM Advanced Communications’s market cap?
BATM Advanced Communications’s market cap is €45.13M.
When is BATM Advanced Communications’s upcoming earnings report date?
BATM Advanced Communications’s upcoming earnings report date is Mar 17, 2027 which is in 159 days.
How were BATM Advanced Communications’s earnings last quarter?
BATM Advanced Communications released its earnings results on Aug 24, 2026. The company reported -€0.005 earnings per share for the quarter.
Is BATM Advanced Communications overvalued?
According to Wall Street analysts BATM Advanced Communications’s price is currently Overvalued.
Does BATM Advanced Communications pay dividends?
BATM Advanced Communications does not currently pay dividends.
What is BATM Advanced Communications’s EPS estimate?
BATM Advanced Communications’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BATM Advanced Communications have?
BATM Advanced Communications has 436,874,180 shares outstanding.
What happened to BATM Advanced Communications’s price movement after its last earnings report?
BATM Advanced Communications reported an EPS of -€0.005 in its last earnings report. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of BATM Advanced Communications?
Currently, no hedge funds are holding shares in DE:BAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BATM Advanced Communications Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
BATM Advanced Communications
BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United States, and Europe. It is structured into two primary business units: Networking and Cyber, and Bio-Medical. The Networking and Cyber division oversees the research, development, manufacturing, and marketing of data communication products. Its key offerings include network function virtualization, carrier Ethernet and MPLS access technologies, and systems for cyber network monitoring. This segment also provides a range of software services, such as training, technical assistance, and laboratory maintenance, in addition to undertaking construction contracts. Conversely, the Bio-Medical division concentrates on the innovation, production, commercialization, and distribution of medical products, with a particular emphasis on laboratory diagnostics and sterilization equipment. Its portfolio features molecular biology diagnostic tools and specialized systems for managing pathogenic and medical waste in critical environments like laboratories, hospitals, pharmaceutical manufacturing plants, and agricultural settings. This division also acts as a distributor for a broad array of diagnostic apparatus and medical consumables from various manufacturers. Notably, BATM has entered into a significant partnership with Novamed Ltd to collaboratively develop and market a home-use testing kit for COVID-19. Established in 1992, the company's corporate headquarters are situated in Hod Hasharon, Israel.
Technical Analysis
EKF Diagnostics Holdings
―
Omega Diagnostics
―
Renalytix
―
Diaceutics
―
Abingdon Health PLC
―